Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2026-02-24 @ 10:20 PM
Study NCT ID:
NCT02877732
Status:
TERMINATED
Last Update Posted:
2018-05-30
First Post:
2016-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D001924', 'term': 'Brain Concussion'}], 'ancestors': [{'id': 'D000070642', 'term': 'Brain Injuries, Traumatic'}, {'id': 'D001930', 'term': 'Brain Injuries'}, {'id': 'D001927', 'term': 'Brain Diseases'}, {'id': 'D002493', 'term': 'Central Nervous System Diseases'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D006259', 'term': 'Craniocerebral Trauma'}, {'id': 'D020196', 'term': 'Trauma, Nervous System'}, {'id': 'D016489', 'term': 'Head Injuries, Closed'}, {'id': 'D014947', 'term': 'Wounds and Injuries'}, {'id': 'D014949', 'term': 'Wounds, Nonpenetrating'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'jghajar@stanford.edu', 'phone': '(650) 725-5562', 'title': 'Dr. Jamshid Ghajar', 'organization': 'Stanford Concussion and Brain Performance Center/ Stanford Emergency Medicine'}, 'certainAgreement': {'piSponsorEmployee': True}}, 'adverseEventsModule': {'timeFrame': 'Study was cancelled by the funder prior to collection of any outcome data; only screening procedures were performed. Adverse Event data was not collected', 'description': 'Study was cancelled by the funder prior to collection of any outcome data; only screening procedures were performed. Adverse Event data was not collected', 'eventGroups': [{'id': 'EG000', 'title': 'Concussed Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.', 'otherNumAtRisk': 0, 'deathsNumAtRisk': 0, 'otherNumAffected': 0, 'seriousNumAtRisk': 0, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Control Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.', 'otherNumAtRisk': 0, 'deathsNumAtRisk': 0, 'otherNumAffected': 0, 'seriousNumAtRisk': 0, 'deathsNumAffected': 0, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Changes in the Measurement of EYE-SYNC Data Immediately After Concussive Event, 2 Days, 7 Days and 14 Days Post Concussive Event.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Concussed Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}, {'id': 'OG001', 'title': 'Control Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}], 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The EYE-SYNC test will be performed immediately after an impact, 2 days, 7 days and 14 days post impact. The movement of eye will be tracked using EYE-SYNC. The data will be recorded in a surface tablet connected to EYE-SYNC.', 'reportingStatus': 'POSTED', 'populationDescription': 'Study was cancelled by the funder prior to collection of any outcome data; only screening procedures were performed.'}, {'type': 'PRIMARY', 'title': 'Reliability of EYE-SYNC Data', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Concussed Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}, {'id': 'OG001', 'title': 'Control Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}], 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The integrity will be analyzed based on the score obtained from EYE-SYNC device.', 'reportingStatus': 'POSTED', 'populationDescription': 'Study was cancelled by the funder prior to collection of any outcome data; only screening procedures were performed.'}, {'type': 'PRIMARY', 'title': 'Integrity of EYE-SYNC Data', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Concussed Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}, {'id': 'OG001', 'title': 'Control Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}], 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The reliability will be analyzed based on the score obtained from EYE-SYNC.', 'reportingStatus': 'POSTED', 'populationDescription': 'Study was cancelled by the funder prior to collection of any outcome data; only screening procedures were performed.'}, {'type': 'SECONDARY', 'title': 'Compare Sport Concussion Assessment Tool (SCAT-3) Test and EYE-SYNC Score', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Concussed Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}, {'id': 'OG001', 'title': 'Control Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}], 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The SCAT-3 result and EYE-SYNC score will be compared.', 'reportingStatus': 'POSTED', 'populationDescription': 'Study was cancelled by the funder prior to collection of any outcome data; only screening procedures were performed.'}, {'type': 'SECONDARY', 'title': 'Compare ANAM-SRT Test and EYE-SYNC Score', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Concussed Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}, {'id': 'OG001', 'title': 'Control Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}], 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The Automated Neuropsychological Assessment Metrics-Simple Reaction Time (ANAM-SRT) evaluation and EYE-SYNC score will be compared.', 'reportingStatus': 'POSTED', 'populationDescription': 'Study was cancelled by the funder prior to collection of any outcome data; only screening procedures were performed.'}, {'type': 'SECONDARY', 'title': 'Compare DEM Test and EYE-SYNC Score', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Concussed Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}, {'id': 'OG001', 'title': 'Control Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}], 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The Developmental Eye Movement (DEM) assessment and EYE-SYNC score will be compared.', 'reportingStatus': 'POSTED', 'populationDescription': 'Study was cancelled by the funder prior to collection of any outcome data; only screening procedures were performed.'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Concussed Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}, {'id': 'FG001', 'title': 'Control Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '6'}, {'groupId': 'FG001', 'numSubjects': '6'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '6'}, {'groupId': 'FG001', 'numSubjects': '6'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '12', 'groupId': 'BG002'}]}], 'groups': [{'id': 'BG000', 'title': 'Concussed Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}, {'id': 'BG001', 'title': 'Control Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM.'}, {'id': 'BG002', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '12', 'groupId': 'BG002'}]}], 'categories': [{'measurements': [{'value': '20', 'groupId': 'BG000', 'lowerLimit': '18', 'upperLimit': '23'}, {'value': '20', 'groupId': 'BG001', 'lowerLimit': '18', 'upperLimit': '23'}, {'value': '20', 'groupId': 'BG002', 'lowerLimit': '18', 'upperLimit': '23'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'FULL_RANGE'}, {'title': 'Sex: Female, Male', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '12', 'groupId': 'BG002'}]}], 'categories': [{'title': 'Female', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}]}, {'title': 'Male', 'measurements': [{'value': '5', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '10', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race and Ethnicity Not Collected', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Race and Ethnicity were not collected from any participant.'}]}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2016-04-12', 'size': 1134355, 'label': 'Study Protocol and Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'Prot_SAP_000.pdf', 'typeAbbrev': 'Prot_SAP', 'uploadDate': '2018-03-27T16:40', 'hasProtocol': True}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'OTHER', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 12}}, 'statusModule': {'whyStopped': 'The funding sponsor elected to terminate the study.', 'overallStatus': 'TERMINATED', 'startDateStruct': {'date': '2016-07'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2018-04', 'completionDateStruct': {'date': '2017-04', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2018-04-29', 'studyFirstSubmitDate': '2016-08-09', 'resultsFirstSubmitDate': '2018-03-27', 'studyFirstSubmitQcDate': '2016-08-19', 'lastUpdatePostDateStruct': {'date': '2018-05-30', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2018-03-27', 'studyFirstPostDateStruct': {'date': '2016-08-24', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2018-04-30', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2017-04', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Changes in the Measurement of EYE-SYNC Data Immediately After Concussive Event, 2 Days, 7 Days and 14 Days Post Concussive Event.', 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The EYE-SYNC test will be performed immediately after an impact, 2 days, 7 days and 14 days post impact. The movement of eye will be tracked using EYE-SYNC. The data will be recorded in a surface tablet connected to EYE-SYNC.'}, {'measure': 'Reliability of EYE-SYNC Data', 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The integrity will be analyzed based on the score obtained from EYE-SYNC device.'}, {'measure': 'Integrity of EYE-SYNC Data', 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The reliability will be analyzed based on the score obtained from EYE-SYNC.'}], 'secondaryOutcomes': [{'measure': 'Compare Sport Concussion Assessment Tool (SCAT-3) Test and EYE-SYNC Score', 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The SCAT-3 result and EYE-SYNC score will be compared.'}, {'measure': 'Compare ANAM-SRT Test and EYE-SYNC Score', 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The Automated Neuropsychological Assessment Metrics-Simple Reaction Time (ANAM-SRT) evaluation and EYE-SYNC score will be compared.'}, {'measure': 'Compare DEM Test and EYE-SYNC Score', 'timeFrame': 'Immediate post impact, 2 days, 7 days and 14 days post impact.', 'description': 'The Developmental Eye Movement (DEM) assessment and EYE-SYNC score will be compared.'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Concussion', 'Athletes', 'Eye-tracking', 'Vision'], 'conditions': ['Eye-tracking']}, 'descriptionModule': {'briefSummary': 'This is a prospective multi-center cohort feasibility and exploratory study.', 'detailedDescription': 'Investigators propose to prospectively study a cohort of 18-25-year-old athletes to establish the reliability of EYE-SYNC data and the utility of the EYE-SYNC eye-tracking device as a sideline concussion assessment tool. The clinical research study will be conducted to 1) determine if eye-tracking, assessed on the sideline by EYE-SYNC eye-tracking device, is a potential marker of injury that can be used in conjunction with other sideline evaluations to inform decisions regarding removal of athletes from play and 2) to use the EYE-SYNC goggle data as a post- injury recovery monitor.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '25 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\nBoth CCS and CTR must meet the following 3 criteria:\n\n* Athletes between the age of 18- 25-years-old.\n* 20/30 or better eyesight (corrected vision allowed).\n* English fluency.\n\nControl Subject:\n\n• Control Subject (CTR) - a teammate of the concussed subject who did not experience impact but who was actively participating in the same sport and session along with the injured teammate at the time of injury\n\nConcussed Subject:\n\nConcussed Subject (CCS) - those who experience impact where concussion is highly suspected as evidenced by impairment in any of the SCAT-3 Domains: Symptoms, Physical Signs, Immediate Memory and Orientation. An Injured Athlete is concussed if he/she is FAIL on the Physical Signs, Score = 0 on the Orientation or Scoring below the cutoff scores on the Symptom Checklist and/or Immediate memory SCAT-3 domains.\n\nA) Symptoms: Rating of 2 or higher on any of the following items:\n\n1. Headaches\n2. Nausea or Vomiting\n3. Dizziness\n4. Balance Problems\n5. Blurred Vision\n6. Feeling Slowed Down\n7. Feeling like "in a fog"\n8. "Don\'t feel right"\n\nB) Physical Signs:\n\nBalance (Leg Stances): Number of Error(s) on any of the following 7 subtests classifies a subject as concussed.\n\nI. Double Leg Stance: At least 3 errors II. Single Leg Stance: At least 3 errors with either dominant or non-dominant foot III. Tandem Stance: At least 3 errors or more.\n\nBalance (Tandem Gait): FAIL on at least 2 of 4 trials:\n\nI. FAIL per trial: more than 14 seconds to complete a trial II. FAIL per trial, if one or more of the following errors are made\n\n1. If step off the line;\n2. Separation between heel and toe\n3. Touch/grab the examiner or an object\n\nD) Orientation: Score = 0 on any of the following 5 items Date: Score = 0 (any date different from current) Month: Score = 0 (any month different from current) Day of the week: Score = 0 (any different from current) Year: Score = 0 (any different from current) Time: Score = 0 AND answer is MORE than + or - 1 hour apart from the correct time.\n\nE) Immediate Memory Recall Total Score = less than 13 words recalled.\n\nExclusion Criteria:\n\n* Clinical diagnosis of a neurological condition including the following: Stroke, Multiple Sclerosis, Epilepsy, Brain Tumor/Cancer, Nystagmus and/or Other major neurological condition.\n* Clinical diagnosis of any of the following eye-sight abnormalities: Uncorrected Amblyopia, Uncorrected Myopia, Uncorrected Presbyopia, Uncorrected Farsightedness, or Uncorrected Astigmatism.\n* Psychiatric history with any of the following:\n\n 1. Clinical diagnosis of a psychotic disorder, bipolar disorder - lifetime\n 2. Clinical diagnosis of ADHD or ADD - Lifetime\n 3. Clinical diagnosis of major depressive disorder - within last year\n 4. Clinical diagnosis of substance abuse disorder - within last year\n 5. Clinical diagnosis of major anxiety disorder - within last year\n\n MEDICATION\n 6. Requires use of a psychotropic medication.\n* Cannot have participated previously in any of the ETA-TV study visits (for instance, a subject that has completed any study visit as a control subject cannot participate as a concussed subject at a later time point).'}, 'identificationModule': {'nctId': 'NCT02877732', 'acronym': 'ETA-TV', 'briefTitle': 'EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2', 'organization': {'class': 'OTHER', 'fullName': 'Stanford University'}, 'officialTitle': 'EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2', 'orgStudyIdInfo': {'id': '20160727'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Concussed Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM. Investigators will be collecting medical history and demographics from each subject.', 'interventionNames': ['Device: EYE-SYNC eye-tracking', 'Other: SCAT-3 subtests', 'Other: DEM', 'Other: Simple Reaction Time subtest of ANAM-SRT', 'Other: Level of Alertnesss']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Control Subject', 'description': 'EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM. Investigators will be collecting medical history and demographics from each subject.', 'interventionNames': ['Device: EYE-SYNC eye-tracking', 'Other: SCAT-3 subtests', 'Other: DEM', 'Other: Simple Reaction Time subtest of ANAM-SRT', 'Other: Level of Alertnesss']}], 'interventions': [{'name': 'EYE-SYNC eye-tracking', 'type': 'DEVICE', 'description': 'The EYE-SYNC® portable eye-tracking system. The eye tracker is a handheld isolated display environment with embedded eye tracking sensors. The eye tracker is connected to a high-performance Windows tablet though a customized docking station. Included accessories with EYE-SYNC are a U.S. tablet power supply adapter and disposable sanitary masks. Participants are asked to follow a dot with their eyes, as the dot moves on the screen of the EYE-SYNC device.', 'armGroupLabels': ['Concussed Subject', 'Control Subject']}, {'name': 'SCAT-3 subtests', 'type': 'OTHER', 'otherNames': ['Sport Concussion Assessment Tool'], 'description': 'Following subtests of SCAT-3 will be administered to the participant: Symptom, Balance, Orientation and Immediate memory', 'armGroupLabels': ['Concussed Subject', 'Control Subject']}, {'name': 'DEM', 'type': 'OTHER', 'otherNames': ['Developmental Eye Movement'], 'description': 'Participant will be asked to read list of numbers out loud from a card', 'armGroupLabels': ['Concussed Subject', 'Control Subject']}, {'name': 'Simple Reaction Time subtest of ANAM-SRT', 'type': 'OTHER', 'otherNames': ['Automated Neuropsychological Assessment Metrics'], 'description': 'Participants will perform Simple Reaction Time sub-test of ANAM-SRT test. They will be asked to click the mouse button every time they see an asterisk on the screen. Participants will perform ANAM-SRT 1 and ANAM-SRT 2 in this study.', 'armGroupLabels': ['Concussed Subject', 'Control Subject']}, {'name': 'Level of Alertnesss', 'type': 'OTHER', 'description': 'Participants will answer questions. This assessment is to assess their alertness level.', 'armGroupLabels': ['Concussed Subject', 'Control Subject']}]}, 'contactsLocationsModule': {'locations': [{'zip': '90089', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'University of Southern California', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '93106', 'city': 'Santa Barbara', 'state': 'California', 'country': 'United States', 'facility': 'University of California Santa Barbara', 'geoPoint': {'lat': 34.42083, 'lon': -119.69819}}, {'zip': '97331', 'city': 'Corvallis', 'state': 'Oregon', 'country': 'United States', 'facility': 'Oregon State University', 'geoPoint': {'lat': 44.56457, 'lon': -123.26204}}, {'zip': '84112', 'city': 'Salt Lake City', 'state': 'Utah', 'country': 'United States', 'facility': 'University of Utah', 'geoPoint': {'lat': 40.76078, 'lon': -111.89105}}], 'overallOfficials': [{'name': 'Jessica A Little, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Stanford University'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Stanford University', 'class': 'OTHER'}, 'collaborators': [{'name': 'Brain Trauma Foundation', 'class': 'OTHER'}, {'name': 'United States Department of Defense', 'class': 'FED'}, {'name': 'Food and Drug Administration (FDA)', 'class': 'FED'}, {'name': 'U.S. Army Medical Research and Development Command', 'class': 'FED'}, {'name': 'Department of Health and Human Services', 'class': 'FED'}], 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Clinical Professor of Neurosurgery', 'investigatorFullName': 'Jamshid Ghajar', 'investigatorAffiliation': 'Stanford University'}}}}